Hearing loss and PRPS1 mutations: Wide spectrum of phenotypes and potential therapy

References

• Arts W.F., Loonen M.C., Sengers R.C. & Slooff J.L. 1993. X-linked ataxia, weakness, deafness, and loss of vision in early childhood with a fatal course. Ann Neurol, 33, 535–539.
   PubMedGoogle Scholar
• Barankiewicz J. & Henderson J.F. 1977. Effect of lowered intracellular ATP and GTP concentrations on purine ribonucleotide synthesis and interconversion. Can J Biochem, 55, 257–262.
   PubMedGoogle Scholar
• Becker M.A. & Kim M. 1987. Regulation of purine synthesis de novo in human fibroblasts by purine nucleotides and phosphoribosylpyrophosphate. J Biol Chem, 262, 14531–14537.
   PubMedGoogle Scholar
• Becker M.A., Puig J.G., Mateos F.A., Jimenez M.L., Kim M. . 1988. Inherited superactivity of phosphoribosylpyrophosphate synthetase: Association of uric acid overproduction and sensorineural deafness. Am J Med, 85, 383–390.
   PubMedGoogle Scholar
• Becker M.A., Heidler S.A., Bell G.I., Seino S., LeBeau M.M. . 1990. Cloning of cDNAs for human phosphoribosylpyrophosphate synthetases 1 and 2 and X chromosome localization of PRPS1 and PRPS2 genes. Genomics, 8, 550–561.
   Google Scholar
• Becker M.A., Smith P.R., Taylor W., Mustafi R. & Switzer R.L. 1995. The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity. J Clin Invest, 96, 2133–2141.
   PubMed Web of Science ®Google Scholar
• Becker M.A., Taylor W., Smith P.R. & Ahmed M. 1996. Overexpression of the normal phosphoribosylpyrophosphate synthetase 1 isoform underlies catalytic superactivity of human phosphoribosylpyrophosphate synthetase. J Biol Chem, 271, 19894–19899.
   PubMedGoogle Scholar
• Becker M.A. 2001. Phosphoribosylpyrophosphate synthetase and the regulation of phosphoribosylpyrophosphate production in human cells. Prog Nucl Acid Res Mol Biol, 69, 115–148.
   PubMedGoogle Scholar
• Becker M.A. 2008. Hyperuricemia and Gout. In: D. Valle, (ed.), The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID). New York: McGraw-Hill, chapter 205.
   Google Scholar
• Benke P.J. & Dittman D. 1977. Phosphoribosylpyrophosphate synthesis in cultured human cells. Science, 198, 1171–1173.
   PubMedGoogle Scholar
• Bottiglieri T. 2002. S-adenosyl-l-methionine (SAMe): from the bench to the bedside: Molecular basis of a pleiotrophic molecule. Am J Clin Nutr, 76, 1151S–1157S.
   PubMed Web of Science ®Google Scholar
• Chiang P.K., Gordon R.K., Tal J., Zeng G.C., Doctor B.P. . 1996. S-Adenosylmethionine and methylation. FASEB J, 10, 471–480.
   PubMed Web of Science ®Google Scholar
• Cui B., Zhang H., Lu Y., Zhong W., Pei G. . 2004. Refinement of the locus for non-syndromic sensorineural deafness (DFN2). J Genet, 83, 35–38.
   PubMedGoogle Scholar
• de Brouwer A.P., Williams K.L., Duley J.A.,van Kuilenburg A.B., Nabuurs S.B. . 2007. Arts syndrome is caused by loss-of-function mutations in PRPS1. Am J Hum Genet, 81, 507–518.
   PubMed Web of Science ®Google Scholar
• de Brouwer A.P.M., van Bokhoven H., Nabuurs S.B., Arts W.F., Christodoulou J. . 2010. PRPS1 mutations: Four distinct syndromes and potential treatment. Am J Hum Genet, 86, 506–518.
   PubMed Web of Science ®Google Scholar
• Garcı´a-Pavı´a P., Torres R.J., Rivero M., Ahmed M., García-Puig J. . 2003. Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young woman. Arthritis Rheum, 48, 2036–2041.
   PubMed Web of Science ®Google Scholar
• Glick N. 2006. Dramatic reduction in self-injury in Lesch-Nyhan disease following S-adenosylmethionine administration. J Inherit Metab Dis, 29, 687.
   PubMed Web of Science ®Google Scholar
• Hartman S.C. & Buchanan J.M. 1958. Biosynthesis of the purines. XXI. 5-Phosphoribosylpyrophosphate amidotransferase. J Biol Chem,233, 451–455.
   PubMedGoogle Scholar
• Kawahara Y., Zinshteyn B., Sethupathy P., Iizasa H., Hatzigeorgiou A.G. . 2007. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science, 315, 1137–1140.
   PubMed Web of Science ®Google Scholar
• Khorana H.G., Fernandes J.F. & Kornberg A. 1958. Pyrophosphorylation of ribose 5-phosphate in the enzymatic synthesis of 5-phosphorylribose 1-pyrophosphate. J Biol Chem, 230, 941–948.
   PubMedGoogle Scholar
• Kim H.J., Sohn K.M., Shy M.E., Krajewski K.M., Hwang M. . 2007. Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5). Am J Hum Genet, 81, 552–558.
   PubMed Web of Science ®Google Scholar
• Kornberg A., Lieberman I. & Simms E.S. 1955. Enzymatic synthesis and properties of 5-phosphoribosylpyrophosphate. J Biol Chem, 215, 389–402.
   PubMed Web of Science ®Google Scholar
• Kremer H., Hamel B.C.J., van den Helm B., Arts W.F.M., de Wijs I.J. . 1996. Localization of the gene (or genes) for a syndrome with X-linked mental retardation, ataxia, weakness, hearing impairment, loss of vision and a fatal course in early childhood. Hum Genet, 98, 513–517.
   PubMedGoogle Scholar
• Lieberman I., Kornberg A. & Simms E.S. 1955. Enzymatic synthesis of pyrimidine nucleotides; orotidine-50-phosphate and uridine-50- phosphate. J Biol Chem, 215, 403–451.
   PubMed Web of Science ®Google Scholar
• Liu H., Peng X., Zhao F., Zhang G., Tao Y. . 2009. N114S mutation causes loss of ATP-induced aggregation of human phosphoribosylpyrophosphate synthetase 1. Biochem Biophys Res Commun, 379, 1120–1125.
   PubMedGoogle Scholar
• Liu X.Z., Han D., Li J., Han B., Ouyang X. . 2010. Loss-of-function mutations in the PRPS1 gene cause a type of nonsyndromic X-linked sensorineural deafness, DFN2. Am J HumGenet, 86, 65–71.
   PubMed Web of Science ®Google Scholar
• Manolis E.N., Eavey R.D., Sangwatanaroj S., Halpin C., Rosenbaum S. . 1999. Hereditary postlingual sensorineural hearing loss mapping to chromosome Xq21. Am J Otol, 20, 621–626.
   PubMedGoogle Scholar
• MillerJr., G.A., Rosenzweig S. & Switzer R.L. 1975. Oxygen-18 studies of the mechanism of pyrophosphoryl group transfer catalyzed by phosphoribosylpyrophosphate synthetase. Arch Biochem Biophys, 171, 732–736.
   PubMed Web of Science ®Google Scholar
• Montero C., Smolenski R.T., Duley J.A. & Simmonds H.A. 1990. S-adenosylmethionine increases erythrocyte ATP in vitro by a route independent of adenosine kinase. Biochem Pharmacol, 40, 2617–2623.
   PubMedGoogle Scholar
• Moran R., Kuilenburg A.B.P., Duley J., Nabuurs S.B., Retno-Fitri A. . 2012. Phosphoribosylpyrophosphate synthetase superactivity and recurrent infections is caused by a p.Val142Leu mutation in PRS-I. Am J Med Genet, Part A, 455–460.
   PubMedGoogle Scholar
• Nyhan W.L. 2005. Disorders of purine and pyrimidine metabolism. Mol Genet Metab, 86, 25–33.
   PubMedGoogle Scholar
• Palella T.D., Andres C.M. & Fox I.H. 1980. Human placental adenosine kinase. Kinetic mechanism and inhibition. J Biol Chem, 255, 5264–5269.
   Google Scholar
• Petersen M.B., Wang Q., Willems P.J. 2008. Sex-linked deafness. Clin Genet, 73, 14–23.
   PubMed Web of Science ®Google Scholar
• Preiss J. & Handler P. 1958. Biosynthesis of diphosphopyridine nucleotide. II. Enzymatic aspects. J Biol Chem, 233, 493–500.
   PubMed Web of Science ®Google Scholar
• Reardon W. 1990. Sex linked deafness: Wilde revisited. J Med Genet, 27, 376–379.
   PubMedGoogle Scholar
• Roessler B.J., Golovoy N., Palella T.D., Heidler S. & Becker M.A. 1991. Identification of distinct PRS1 mutations in two patients with X-linked phosphoribosylpyrophosphate synthetase superactivity. Adv Exp Med Biol, 309B, 125–128.
   PubMedGoogle Scholar
• Rosenberg R.N. & Chutorian A. 1967. Familial opticoacoustic nerve degeneration and polyneuropathy. Neurology, 17, 827–832.
   PubMedGoogle Scholar
• Ross B.M., Moszczynska A., Blusztajn J.K., Sherwin A., Lozano A. . 1997. Phospholipid biosynthetic enzymes in human brain. Lipids, 32, 351–358.
   PubMedGoogle Scholar
• Schuster S. & Kenanov D. 2005. Adenine and adenosine salvage pathways in erythrocytes and the role of S-adenosylhomocysteine hydrolase: A theoretical study using elementary flux modes. FEBS J, 272, 5278–5290.
   PubMedGoogle Scholar
• Simmonds H.A., Fairbanks L.D., Duley J.A. & Morris G.S. 1989. ATP formation from deoxyadenosine in human erythrocytes: Evidence for a hitherto unidentified route involving adenine and S-adenosylhomocysteine hydrolase. Biosci Rep, 9, 75–85.
   PubMedGoogle Scholar
• Smolenski R.T., Montero C., Duley J.A. & Simmonds H.A. 1991. Effects of adenosine analogues on ATP concentrations in human erythrocytes: Further evidence for a route independent of adenosine kinase. Biochem Pharmacol, 42, 1767–1773.
   Google Scholar
• Smolenski R.T., Fabianowska-Majewska K., Montero C., Duley J.A., Fairbanks L.D. . 1992. A novel route of ATP synthesis. Biochem Pharmacol43, 2053–2057.
   PubMedGoogle Scholar
• Sperling O., Eilam G., Persky-Brosh S. & de Vries. 1972. Accelerated erythrocyte 5-phosphoribosyl-1-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout.Biochem Med, 6, 310–316.
   PubMedGoogle Scholar
• Taira M., Iizasa T., Yamada K., Shimada H. & Tatibana M. . 1989. Tissue-differential expression of two distinct genes for phosphoribosylpyrophosphate synthetase and existence of the testis-specific transcript. Biochim Biophys Acta, 1007, 203–208.
   PubMedGoogle Scholar
• Tyson J., Bellman S., Newton V., Simpson P., Malcolm S. . 1996. Mapping of DFN2 to Xq22. Hum Mol Genet, 5, 2055–2060.
   PubMed Web of Science ®Google Scholar